Form D · Biotechnology

Human Longevity, Inc.

San Diego, CA · CIK 0001781303

Offering snapshot reported Aug 21, 2024 · SEC filing

Reported sold
$32M
Offering amount: $32M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 13, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$16M$32MApr 7, 2023: $10,500,000.00Apr 7, 2023Aug 21, 2024: $31,999,999.00Aug 21, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,500,000 → $31,999,999
  • Reported investors4 → 18

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 21, 2024Amendment$31,999,999$21,499,999vs Apr 7, 202318SEC filing
Apr 7, 2023Initial$10,500,000No comparison4SEC filing
Oct 11, 2022Initial$6,919,380No comparison11SEC filing
Jul 1, 2019Initial$20,060,630No comparison1SEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-478201

Source: Form D, filed Aug 21, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Wei Wu He Director
James Hu Director, Executive
James Huang Director
David Karow Director, Executive
Helmut Schuehsler Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4570 Executive Drive
San Diego, CA, 92121